secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K/A
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001193125-24-157373
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics estimates $3.9-4.1M in charges from workforce reduction of up to 87 employees
--------------------------------------------------------------------------------

- Board approved workforce reduction of up to 87 employees, effective May 21 and June 20, 2024.
- Cost estimate: $3.9 to $4.1 million, primarily severance and benefits.
- Majority of charges expected in Q2 2024.
- Company previously could not estimate costs; this 8-K/A provides updated disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524157373/0001193125-24-157373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524157373/d837500d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-157373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer